Abstract:The RNA molecule plays a pivotal role in many biological processes by relaying genetic information, regulating gene expression, and serving as molecular machines and catalyzers. This inherent versatility of RNA has fueled significant advancements in the field of RNA nanotechnology, driving the engineering of complex nanoscale architectures toward biomedical applications, including targeted drug delivery and bioimaging. RNA polymers, serving as building blocks, offer programmability and predictability of Watson-Crick base pairing, as well as non-canonical base pairing, for the construction of nanostructures with high precision and stoichiometry. Leveraging the ease of chemical modifications to protect the RNA from degradation, researchers have developed highly functional and biocompatible RNA architectures and integrated them into preclinical studies for the delivery of payloads and imaging agents. This review offers an educational introduction to the use of RNA as a biopolymer in the design of multifunctional nanostructures applied to targeted delivery in vivo , summarizing physical and biological barriers along with strategies to overcome them. Furthermore, we highlight the most recent progress in the development of both small and larger RNA nanostructures, with a particular focus on imaging reagents and targeted cancer therapeutics in pre-clinical models and provide insights into the prospects of this rapidly evolving field.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to achieve targeted drug delivery and imaging using RNA nanostructures. Specifically, the authors explored how to overcome physical and biological barriers in in - vivo applications by designing and constructing RNA nanostructures, in order to increase the local concentration of drugs in diseased tissues or organs while reducing toxicity to healthy tissues. In addition, the paper also discussed the potential applications of RNA nanostructures in non - invasive imaging techniques. These techniques can significantly benefit from targeted methods through fluorescent or radioactive - labeled tracers, thereby providing more detailed molecular characterizations, which are helpful for disease diagnosis and prognosis evaluation. The key points mentioned in the paper include: - **Versatility and biocompatibility of RNA**: RNA molecules not only play important roles in many biological processes, but also their unique programmability and biocompatibility make them ideal materials for constructing multifunctional nanostructures. - **Chemical modification and functionalization**: In order to improve the stability and functionality of RNA nanostructures, researchers have introduced a variety of chemical modification methods, such as phosphorothioate (PS) modification, 2' - fluoro (2' - F), 2' - O - methyl (2' - OMe) or 2' - O - methoxyethyl (2' - MOE) modification, etc. These modifications can protect RNA from nuclease degradation and reduce immunogenicity. - **Immunogenicity, pharmacokinetics and biodistribution**: The paper discussed the challenges of the immune system faced by RNA nanostructures in in - vivo applications and their impacts on pharmacokinetics and biodistribution, and proposed corresponding solutions, such as using "self" biomolecules or peptides for coating treatment, and optimizing their biodistribution by controlling the size and shape of RNA nanostructures. - **Functionalization of targeting ligands and imaging tracers**: In order to achieve targeted drug delivery and imaging, RNA nanostructures can be designed as multifunctional nanocarriers by combining with specific targeting ligands and detection elements. The paper introduced in detail several commonly used bioconjugation strategies, such as amine - NHS reaction, thiol - maleimide reaction, copper(I) - catalyzed azide - alkyne cycloaddition (CuAAC), copper - free strain - promoted azide - alkyne cycloaddition (SPAAC) and inverse - electron - demand Diels - Alder (iEDDA) reaction, etc. In summary, this paper aims to provide references and guidance for future clinical translation in this field by reviewing the progress in the design, chemical modification, functionalization of RNA nanostructures and their applications in targeted drug delivery and imaging.

RNA nanostructures for targeted drug delivery and imaging

DNA-based nanostructures for RNA delivery

Therapeutic applications of RNA nanostructures

RNA Nanomedicine: Delivery Strategies and Applications

RNA Cancer Nanomedicine: Nanotechnology-Mediated RNA Therapy.

Multifunctional nucleic acid nanostructures for gene therapies

Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis

RNA-based Therapeutics: an Overview and Prospectus

Nucleic Acid Armor: Fortifying RNA Therapeutics through Delivery and Targeting Innovations for Immunotherapy

DNA nanomaterials for preclinical imaging and drug delivery

RNA nanotechnology: a new chapter in targeted therapy

Targeting RNA with small molecules, from RNA structures to precision medicines: IUPHAR review: 40

Recent advances in DNA nanostructure‐enabled drug delivery

Innovative developments and emerging technologies in RNA therapeutics

Stimuli‐Responsive Nanotechnology for RNA Delivery

Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies

RNA-Binding Small Molecules in Drug Discovery and Delivery: An Overview from Fundamentals

DNA Nanostructure‐Based Systems for Intelligent Delivery of Therapeutic Oligonucleotides

Nucleic acid drug and delivery techniques for disease therapy: present situation and future prospect (1/2024)

Nano-based delivery of RNAi in cancer therapy

Targeting RNA structures with small molecules